Associated Papers
Redundant meta-analyses are common in genetic epidemiology.
Sigurdson MK et al.
Journal of Clinical Epidemiology, 2020
Single nucleotide polymorphisms, variable number tandem repeats and allele influence on serotonergic enzyme modulators for aggressive and suicidal behaviors: A review.
Xiang C et al.
Pharmacology, Biochemistry, and Behavior, 2019
Pharmacogenetics analysis of serotonin receptor gene variants and clinical response to risperidone in Han Chinese schizophrenic patients.
Zhou W et al.
Neuroscience Letters, 2018
Association of Serotonin Receptors with Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis.
Hou YW et al.
Current Medical Science, 2018
Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis.
Numata S et al.
Frontiers in Pharmacology, 2018
A review of genetic alterations in the serotonin pathway and their correlation with psychotic diseases and response to atypical antipsychotics.
Baou M et al.
Schizophrenia Research, 2016
Ethnicity moderates the association between 5-HTTLPR and national suicide rates.
Schild AH et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research, 2014
Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population.
Almoguera B et al.
The Pharmacogenomics Journal, 2013
Meta-analyses of 8 polymorphisms associated with the risk of the Alzheimer's disease.
Xu X et al.
Plos One, 2013
Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response.
Xu Z et al.
Journal of Psychopharmacology (oxford, England), 2012
Serotonin 6 receptor gene and schizophrenia: case-control study and meta-analysis.
Kishi T et al.
Human Psychopharmacology, 2012
Recent molecular genetic studies and methodological issues in suicide research.
Tsai SJ et al.
Progress in Neuro-psychopharmacology & Biological Psychiatry, 2011
Association analysis of TPH2, 5-HT2A, and 5-HT6 with executive function in a young Chinese Han population.
Gong P et al.
Journal of Neurogenetics, 2011
Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.
Zhang JP et al.
Expert Opinion on Drug Metabolism & Toxicology, 2011
Pharmacogenetics of antidepressants.
Crisafulli C et al.
Frontiers in Pharmacology, 2011
Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population.
Kishi T et al.
Human Psychopharmacology, 2010
Serotonin 6 receptor gene and mood disorders: case-control study and meta-analysis.
Fukuo Y et al.
Neuroscience Research, 2010
Lack of association between five serotonin metabolism-related genes and medication overuse headache.
Cevoli S et al.
The Journal of Headache and Pain, 2010
Male specific association between the 5-HTR6 gene 267C/T SNP and suicide in the Portuguese population.
Azenha D et al.
Neuroscience Letters, 2009
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia.
Fijal BA et al.
The Pharmacogenomics Journal, 2009
Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy.
Wilkie MJ et al.
The Pharmacogenomics Journal, 2009
Association of unipolar depression with gene polymorphisms in the serotonergic pathways in Han Chinese.
Shi M et al.
Acta Neuropsychiatrica, 2008
Why do young women smoke? IV. Role of genetic variation in the dopamine transporter and lifetime traumatic experience.
Segman RH et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2007
No association of 5-HT2C, 5-HT6, and tryptophan hydroxylase-1 gene polymorphisms with personality traits in the Japanese population.
Tochigi M et al.
Neuroscience Letters, 2006
No association of attention-deficit/hyperactivity disorder with genes of the serotonergic pathway in Han Chinese subjects.
Li J et al.
Neuroscience Letters, 2006
The molecular genetic architecture of human personality: beyond self-report questionnaires.
Ebstein RP
Molecular Psychiatry, 2006
Lack of an association between 5-HT receptor gene polymorphisms and suicide victims.
Okamura K et al.
Psychiatry and Clinical Neurosciences, 2005
Association between the 5-HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder.
Lee SH et al.
Psychiatry and Clinical Neurosciences, 2005
Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.
Lotrich FE et al.
Neuropsychiatric Disease and Treatment, 2005
Pharmacogenetics as a tool in the therapy of schizophrenia.
Wilffert B et al.
Pharmacy World & Science : Pws, 2005
Association of the HTR6 polymorphism C267T with late-onset Alzheimer's disease in Chinese.
Kan R et al.
Neuroscience Letters, 2004
PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations.
Hatano Y et al.
Neurology, 2004
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
Kirchheiner J et al.
Molecular Psychiatry, 2004
Family-based association study of the serotonin-6 receptor gene (C267T polymorphism) in schizophrenia.
Dubertret C et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2004
5-Hydroxytryptamine 6 receptor (5-HT(6)) receptor and apolipoprotein E (ApoE) polymorphisms in patients with Alzheimer's disease in the Basque Country.
Alvarez-Alvarez M et al.
Neuroscience Letters, 2003
Association study of oestrogen receptor alpha gene polymorphism and suicidal behaviours in major depressive disorder.
Tsai SJ et al.
Psychiatric Genetics, 2003
Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia.
Segman RH et al.
The Pharmacogenomics Journal, 2003
Pharmacogenomics in schizophrenia: the quest for individualized therapy.
Basile VS et al.
Human Molecular Genetics, 2002
Association study of angiotensin I-converting enzyme polymorphism and symptomatology and antidepressant response in major depressive disorders.
Hong CJ et al.
Journal of Neural Transmission (vienna, Austria : 1996), 2002
Association study of the 5-hydroxytryptamine(6) receptor gene in Alzheimer's disease.
Orlacchio A et al.
Neuroscience Letters, 2002
Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson's disease.
Messina D et al.
Neurology, 2002
Association analysis for the genetic variants of the NMDA receptor subunit 2b and Alzheimer's disease.
Tsai SJ et al.
Dementia and Geriatric Cognitive Disorders, 2002
Association analysis of a functional catechol-o-methyltransferase gene polymorphism in schizophrenic patients in Taiwan.
Liou YJ et al.
Neuropsychobiology, 2001
Serotonin 6 receptor polymorphism in schizophrenia: frequency, age at onset and cognitive function.
Chiu HJ et al.
Neuropsychobiology, 2001
Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders.
Wu WH et al.
Neuropsychobiology, 2001
Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease.
Thome J et al.
Journal of Neural Transmission (vienna, Austria : 1996), 2001
Recent progress in psychiatric genetics-some hope but no hype.
Stoltenberg SF et al.
Human Molecular Genetics, 2000
Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia.
Vogt IR et al.
American Journal of Medical Genetics, 2000
Association study of apolipoprotein E epsilon4 with clinical phenotype and clozapine response in schizophrenia.
Hong CJ et al.
Neuropsychobiology, 2000